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The Effects of Clinical Interventions 
on Use of Medicines with a Focus 
on Antibiotics
3.1  Systematic Review of Interventions on Antibiotic Prophylaxis for 









To systematically review intervention studies on antibiotic prophylaxis in clean or clean-contaminated 
surgery in Chinese hospitals from 2000 to 2012. Published peer reviewed articles, unpublished 
documents and reports, and gray literatures were identified through searching CNKI, CBM, VIP, 
PubMed (MEDLINE), WHO database, and the official websites of the Ministry of Health of China, 
provincial health authorities and medical university internal publications. Eighty-two studies were 
identified. Circulation and localization of central rules, regulations and guidelines; clinical pharmacists’ 
involvement; technical, administrative, and managerial strategies were the mostly adopted 
interventions. Except one study, all claimed effectiveness of interventions. Limited effects were 
observed for non-indicated clean surgery. Huge gaps still existed between the international agreed 
guidelines and the claimed best performance following interventions. The following were critical to 
have more effective interventions: recognition, acceptance, and enforcement strategies of rules, 
regulations, and guidelines; intervention persistence and intensity; health information system; removal 
of health system perverse incentives; patient–doctor relationship; public education; and access to 
unbiased medicines information. A total 4 of 82 studies were pre–post studies with control; all others 
were simple pre–post studies without control. Simple measurement of the outcome indicators as 
an average for pre–post intervention groups and changes in between failed to distinguish the real 
intervention effect from confounding factors, and failed to adjust underlying trends. Interventions on 
surgical antibiotic prophylaxis in Chinese hospitals during 2000–2012 brought limited positive effects. 
There are still huge gaps between the Chinese situation and internationally agreed standards. More 
advanced study methodologies are needed to have better documentation of evidence of the most 
effective interventions.
 




World Health Assembly (WHA) resolutions urged member states to formulate measures to 
promote appropriate and cost-effective use of antibiotics.1 The National Health and Family 
Planning Commission of P.R. China (formerly named the Ministry of Health, MoH) committed 
to this. They developed series regulations and rules on medicines use in health facilities. These 
included regulations on health facility pharmacy,2 retail pharmacies sell antimicrobials with 
prescriptions,3 national standard clinical guidelines for antibiotics use,4 national antimicrobials 
clinical use and resistance monitoring network in hospitals,5 standardized format of prescription 
and procedure of dispensing,6 and restriction of antimicrobials stocked and used in different 
levels of public health facilities in 2012.7 
Meanwhile, the World Health Organization (WHO) and the Chinese government jointly conducted 
interventions on antibiotics use in hospitals across China. Antibiotic prophylaxis in surgery was 
prioritized due to its severe inappropriate use in Chinese hospitals.8 Beijing, Zhuhai, Guangdong, 
Jiangxi, Anhui, and Guangxi9-14 reported the above interventions accordingly. Some local authorities 
followed this and conducted similar interventions to improve antibiotic prophylaxis in surgery. 
MATERIALS AND METHODS
This study systematically identified and studied published peer reviewed articles, unpublished 
documents and reports, and gray literatures about antibiotic prophylaxis in clean or clean-
contaminated surgery in Chinese hospitals during 2000–2012, and analyzed the effects of 
reported interventions and study methods, and the key determinants of antibiotic prophylaxis in 
surgery in Chinese hospitals. 
Published peer reviewed articles were identified through searching CNKI, CBM, and VIP. Four Chinese 
terms were used to search the title, abstract and key words: prevention, antibiotics, antimicrobials, 
and intervention. Considering the possible difference between Chinese and English meaning of the 
same word, and only targeting studies about China, three English terms were used in searching the 
title and abstract of PubMed (MEDLINE): antibiotic prophylaxis, intervention, China. The study also 
reviewed reference lists of published articles to obtain earlier relevant articles. 
In addition to peer reviewed literature, this study performed a systematic review of published and 
unpublished reports and documents. Chinese materials were obtained from the MoH and its working arms, 
such as the national antibiotics clinical use monitoring network, and other relevant research organizations. 
We searched the official website of MoH, provincial health authorities and medical university internal 
publications (including master and PhD thesis). English materials were obtained from WHO database of 
studies on use of medicines in developing and transitional countries. This database includes systematically 
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extracted information from published and unpublished articles and reports. It also contains information 
on interventions on medicines use reported by these studies. All studies in this database were published 
during 1990–2009. It has not been updated since 2009. Several relevant project reports of WHO country 
cooperation projects in China were identified through this way. 
RESULTS
As showed in Table 1, 82 published studies were identified, which included eight articles of gray 
literatures (five in Chinese, three in both English and Chinese), and 74 peer reviewed articles (72 
in Chinese, two in English). These articles contained studies about interventions on antibiotic 
prophylaxis in clean or clean-contaminated surgery in Chinese hospitals during 2000–2012. 
According to the infection control categories defined by the MoH,15 58 targeted category I 
incision (clean surgery), and 24 targeted category I and II incision (clean-contaminated surgery). 
A total 3 of 82 reviewed studies were published before 2005. The earliest published articles came 
from Beijing9,10 and Guangdong11,12,16,17 supported by WHO. A total 59 of 82 articles were published 
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Table 1 Characteristics of 82 included articles
All interventions were in public hospitals. As showed in Table 2, 81 of 82 reviewed articles were research 
articles,9-14,16-21 and one was review paper containing evidence from other articles and reports.18
 A total 4 of 81 research articles were pre–post studies with control.13,14,19,20 A total 77 of 81 articles 
were simple pre–post studies without control. Although they named pre-group (non-intervention) 
as control group, they only measured the outcome indicators as an average for pre-group (non-
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intervention) before interventions, and for post-group (intervention) after interventions, and 
calculated changes in between. 
A total 10 of 77 simple pre–post studies assessed the difference between pre-group (non-
intervention group) and post-group (intervention group) in terms of age, sex, and severity of 
diseases,16,21-25 or designed appropriate data collection plan to avoid seasonal variations.16,21,22,26-29 
As shown in Table 3, a total 18 of 81 studies adopted rule, regulation and guideline approach. 
Circulation and localization of centrally developed rules, regulations and guidelines were common 
approaches; others were guideline training course and examination, newsletter and broader 
circulation, and experience sharing with other hospitals.9-14,16,17,22-31 
A total 41 of 81 studies used clinical pharmacist to conduct interventions. Clinical pharmacist worked 
on-site with surgeons to decide antibiotics selection, dosage and strength, administration route 
and time, and took joint ward rounds. They collected drug utilization data, evaluated the degree of 
guideline compliance, gave feedback and recommendations to surgeons regularly.9-14,19-29,31–54 15 of 
39 studies reported that clinical pharmacists conducted continued quality improvement initiative, 
for example, monitor-training-planning (MTP).11–14,20,22,23,32,34,35,37,44,45,55,56 A total 13 of 39 studies claimed 
positive role of clinical pharmacist in improving antibiotic prophylaxis in surgery.26,41–50,54,56
A total 12 of 81 studies introduced electronic prescription and medical record management 
system. Electronic prescription and medical record management system were developed 
to achieve real time monitoring and evaluation of antibiotics use, and electronic control of 
antibiotics use (alert to non-compliance prescriptions).16,19–22,25,27,42,43,53,57,58 
A total 12 of 81 studies adopted administrative and managerial strategy. Restriction of antibiotics 
prescribing rights of surgeons based on levels of technical skills; strengthening the accountability 
of hospital managers and department directors through signing commitment documents; setting 
up antibiotics clinical use supervision group under the leadership of hospital managers; integrating 
antibiotics use performance assessment into quality of care accreditation process; naming, shaming and 
economic punishment to bad performances, praising and rewarding to good performances.19,23,26,29,57,59–65 
Category n
Research articles 81
Review  articles 1
Pre-post with control 4
Pre-post without control 77
Similarity of cases considered between pre-post groups 10




Rules, regulations and guidelines approach 18
Clinical pharmacist 41
Electronic prescription and medical record management system 12
Administrative and managerial strategy 12
Table 3  Intervention approach
As shown in Table 4, all studies selected the following measurements based on Chinese national 
guidelines: antibiotics selection and changing, dose, solvent, admission routes and timing, and 
combination. A total 17 of 81 measured surgical site infection rate.10,14,16,17,20–22,34,35,40,53,58,66–70
A total 5 of 81 studies assessed adverse drug reaction rate.19,29,41,49,71 A total 34 of 81 studies 
counted medical and medicines expenditures.9,10,16,17,19–23,25,29,32,36,41,43,48,49,51,52,54,56,58,59,66–69,72–78 A total 9 
of 81 studies compared duration of hospitalization.20,29,30,41,44,66,67,74,79 
Outcome measurement n
Antibiotics selection and changing, dose, solvent, admission routes and timing, combination 81
Surgical site infection rate 17
Adverse drug reaction rate 5
Medical and medicines expenditures 34
Duration of hospitalization 9
Table 4  Outcome measurement
As showed in Table 5, only one study claimed failure in improving antibiotic prophylactic in a 
Chinese hospital,80 all others concluded effectiveness of interventions. There were limited effects 
on non-indicated clean surgery, especially clean-contaminated surgery. This was because that 
surgeon concerned about failure to control hygiene risks in operating theatres, and patients’ 
complains in case of having infections.12,17,40,44,81–83 
A total 24 of 81 studies reported that the proportion of clean surgery used antibiotics reduced 
from 21.3–100% to 3.2–90%;18,23,25,35,37,41,44–46,56,58,59,66,74–76,79,80,84–89 9 of 81reported that the proportion of 
antibiotic prophylaxis 0.5–2 hours before incision increased from 7.7–60% to 31–92%; 20,25,37,45,47,60,72,77,88 
5 of 81 reported that the proportion of antibiotic prophylaxis <24 hours increased from 0–5% to 
46–81%;23,45,47,76,90 2 of 81 reported that the proportion of cases used no antibiotics after operation 
increased from 0–62% to 39–96%;36,91 26 of 81 reported that the No. of days for antibiotic prophylaxis 
reduced from 2–16 to <24 hours-11;11,12,18,29,34,36–38,42–49,52,56–58,60,65,69,70,78,81 9 of 81 reported that the 
proportion of combination therapy reduced from 4–100% to 0–21%;11,12,29,41,48,55,58,67,75 7 of 81 reported that 
the number of days for hospitalization reduced from 6–16 to 2–6.28,29,32,44,66,70,74


















R a t i o n a l i t y  s c o r e s  o f 
indicated clean surgery 
with antibiotic prophylaxis
55.4a 77b 57.6a 64.3b
Proportion of non-indicated 
clean surgery admitted no 
antibiotics
61.9%c 60.9%d 84.4%c 59.1%d
Sun20
P r o p o r t i o n  o f  n o n -
indicated clean surgery 
with antibiotic prophylaxis
75%e 32.56%e 44.23%f 42.05%f
Proportion of clean surgery 
admitted no antibiotics 
after operation
0.96% 39.5% 0※ 1.1%
Table 6  Quantitative intervention effect of three controlled studies
Notes:
a.  t-test P> 0.05, no significant difference between intervention and control group pre intervention.
b.  t-test P< 0.05, significant difference between intervention and control group post intervention.
c.  Chi2-test P< 0.05, significant difference between intervention and control group pre intervention.
d. Chi2-test P> 0.05, no significant difference between intervention and control group post 
intervention.
e. P < 0.05, significant difference of intervention group pre and post intervention.
f.  P > 0.05, no significant difference of control group pre and post intervention. 
Measurement Outcome No. of research
articles
Overall effect of intervention Effective 80/81
% of clean surgery used antibiotics Reduced from 21%-100% to 3%-90% 24/81
% of antibiotic prophylaxis 0.5-2h before incision Increased from 7.7%-60% to 31%-92% 9/81
% of antibiotic prophylaxis <24 h Increased from 0-5% to 46%-81% 5/81
% of cases used no antibiotics after operation Increased from 0-62% to 39%-96% 2/81
No. of days for antibiotic prophylaxis Reduced from 2-16 to <24 h-11 26/81
% of combination therapy Reduced from 4%-100% to 0-21% 9/81
No. of days for hospitalization Reduced from 6-16 to 2-6 7/81
Table 5  Outcome of intervention
The outcome reported by the three controlled studies was summarized as showed in Table 6. The 
WHO supported project13 and Zheng14 found that, the rationality scores of indicated clean surgery 
with antibiotic prophylaxis of the  intervention group increased from 55.4 to 77.0, and that of the 
control group also increased from 57.6 to 64.3. 
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The difference between the intervention and control group was not significant before 
interventions (p>0.05), but was significant following interventions (p<0.05). This implied positive 
effect of interventions on increasing the rationality scores of indicated clean surgery with 
antibiotic prophylaxis. 
The proportion of non-indicated clean surgery with antibiotic prophylaxis of the intervention 
group slightly dropped from 61.9% to 60.9%, while that of the control group significantly dropped 
from 84.4% to 59.1%. The difference between the intervention and control groups was significant 
before intervention (p<0.05), but was not significant (p>0.05) following interventions. This 
indicated other factors to affect surgeons’ decision on antibiotics use for non-indicated clean 



















NA Grades of 
recommendations 
based on levels of 
evidence
Not recommended 
in general, except 
high risk factors
32.6%-39.1% non-indicated 






minutes before the skin 
is incised
0.5-2 hours before 
surgery
31.4%-92.4% antibiotic 




NA Single standard dose 
is sufficient under 
most circumstances. 
Additional dosage may 
be indicated for longer 
surgery or shorter-
acting agents, and 
intra-operative blood 
loss in adults (>1,500 
ml)/children (25 ml/kg) 
after fluid replacement. 
Duration<24 hours
Single dose for 
clean surgery <2 
hours. 2nd dose 
could be given 
when surgery >3 
hours or blood 
loss >1,500 ml. 
Duration<24 
hours, could be 
prolonged to 48 
hours for specific 
circumstances
39.5%-96% of clean 
surgery with no antibiotic 
prophylaxis after 
operation,20,34
average number of days 
for antibiotic prophylaxis 
was 4.1±2.9 (X ± SD)13,14
Medicines
choice
NA Narrow spectrum, less 
expensive antibiotics 





cost should be 
considered
2nd & 3rd generations 
of cephalosporins were 
the most commonly used 
antibiotics22,34,47,67,79
Table 7  Surgical prophylaxis guidelines & reported best performance after intervention in Chinese 
hospitals
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of the studied cases in the control and intervention groups. Proportion of clean surgery with 
antibiotic prophylaxis of the intervention group significantly decreased from 100% to 60.5% 
(p<0.05), while that of the control group changed from 100% to 98.9% (p>0.05). Proportion 
of clean surgery without antibiotic prophylaxis after operation of the intervention group 
significantly increased from 1.0% to 39.5% (p<0.05), while that of the control group changed from 
0 to 1.1% (p>0.05). Proportion of non-indicated clean surgery with antibiotic prophylaxis of the 
intervention group significantly reduced from 75.0% to 32.6% (p<0.05), while that of the control 
group changed from 44.2% to 42.1% (not significant, p> 0.05). 
The best performances claimed by the reviewed studies were compared with the international 
guideline, the internationally recognized national guideline, and the Chinese national guideline 
in Table 7. Although Chinese national guideline recommends that antibiotic prophylaxis is not 
necessary for non-indicated clean surgery, 32.6–39.1% of them still used antibiotics; 31.4–92.4% 
cases were in line with the recommendation of international and national guidelines: antibiotic 
prophylaxis 0.5–2 hours before incision; 39.5–96.0% of clean surgery did not use antibiotics after 
operation, the average number of days using antibiotics was 4.1 ± 2.9 (X ± SD), although both 
the Scottish and Chinese national guideline recommend that single standard dose is sufficient 
under most circumstances, and duration for antibiotic prophylaxis should <24 hours for special 
cases; Narrow spectrum antibiotics were recommended by the Scottish Guideline, Class II and III 
generations of cephalosporin were the most commonly used antibiotics. 
DISCUSSION
Intervention effect evaluation criteria
Even though the Chinese guideline is generally not as stringent as the international/internationally 
recognized national guidelines, huge gaps still existed between the Chinese guideline and the 
claimed best performances following interventions. This indicates that, the situations after 
intervention are still not optimistic. 
Lessons learnt from the reviewed literature
According to the experiences summarized by the reviewed literature, the following aspects are 
critical to have more effective interventions: 
Enforcement of rules and regulations and guidelines 
The MoH of China issued a series of rules and regulations and guidelines. Most of them were 
general principles but not operational details. Putting them into good practice in hospitals was 
problematic without effective implementing strategies. Identification and recognition of centrally 
issued rules and regulations and guidelines based on actual situation, and developing operational 
implementation strategies were crucial for better enforcement.13,14,18,27,48 
Chapter 3
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Acceptance and compliance of guidelines 
Contradictions exist among guidelines issued by different government agencies and professional 
associations. Well organized expert consultation process and standardized evidence-based 
mechanism for guideline development are premise for more authoritative guideline and better 
acceptance and compliance at local levels.14,18 
Intervention intensity
Promoting appropriate use of antibiotics requires continued efforts, one-time project based 
intervention, or pure executive order won’t have sustainable effects.11–14,18,25,35,38,59 Continued 
efforts with repeated MTP circles have better effects on changing prescribing behaviors than 
pure guideline circulation and training.11–14,20,22,23,34,35,37,44,45,55,56 Naming and shaming, economic 
punishment for bad performances, praising and rewarding to good performances are helpful for 
better guideline compliance.19,23,26,29,57,59–65 
Health information system
Electronic prescribing management system enables real time monitoring of antibiotics prescribing, 
timely alert of prescriptions not complied with guidelines, and easy utilization analysis. It is an 
efficient tool for easy regular monitoring, data collection, evaluation, feedback, and information 
sharing.16,19–22,25,27,42,43,53,57,58 
Health system problems
Technical interventions have limited effect in convincing surgeons not to use antibiotics for non-
indicated cases. Complicated problems exist which are beyond the knowledge and prescribing 
habits of surgeons. Perverse incentives in health systems have driven doctors to use expensive 
and broad spectrum antibiotics even for non-indicated cases.18 These perverse incentives include 
prices of both labor and skill extensive medical services are set by the government far below the 
real cost, surgeons have to rely on selling medicines and diagnostic tests to collect revenue and 
to compensate low salary. 
Patient–doctor relationship
Poor accessibility and affordability to quality care and low formal salary but heavy workload 
have brought huge pressures to both patients and doctors. Such pressures lead to deteriorated 
patient–doctor relationship. Placing the responsibility of proof on doctors in medical disputes 
about unexpected infections may also be a factor for inappropriate antibiotic prophylaxis. 
Surgeons are risk-averse for those clean contaminated surgeries, and high risk ones, such as 
cesarean section.11,12,14,18,20,23,39,58,62 
Public education
Public education on prudent use of antibiotics is weak.9,14,18,20,70 General public always have 
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incorrect perceptions about antibiotic use for cold, cough, fever, and other non-bacterial 
infections. People always regard the brand new and broad-spectrum antibiotics as “big guns.” 
Unbiased medicines information
Clinical pathway and guideline are just newly introduced and not yet accepted nationwide. Timely 
access to evidence-based medicines information has been weak in less developed areas. There is 
no well recognized, officially launched, friendly and public accessed channels for evidence-based 
medicines information dissemination.14,18 
Intervention effect evaluation method
Making conclusions on successfulness of intervention needs rigorous research methods. There is a 
need for adopting more advanced method for policy impact analysis. Lots of studies claimed positive 
effects. However, simple pre–post study without control failed to distinguish the real intervention 
effect from the confounding factors. Simple before-after comparison without consideration of 
difference between pre-group (non-intervention) and post group (intervention) and seasonal 
variations, could not adjust underlying trends. In addition, calculating average outcome measurement 
for pre–post groups, and not using advanced statistical techniques (such as segmented regression) to 
analyze the data, was a rough estimation rather than an accurate quantification. 
CONCLUSION
Interventions on antibiotic prophylaxis in clean and clean contaminated surgery in Chinese 
hospitals during 2000–2012 brought limited positive effects. There are gaps between the Chinese 
situation and international standards. It is not yet a time for concluding a successfulness of 
these interventions. Simple pre–post study without a well designed control group might not 
be appropriate for drawing any conclusions of the intervention effect. The most outstanding 
problem for interventions is non-indicated antibiotic prophylaxis. This indicates that there might 
be complex factors which affected surgeons’ antibiotic prophylaxis decision making, such as 
health system problems and patients’ expectations. More comprehensive approaches and 
continued efforts are needed. More advanced methodologies are needed to better document 
evidences for the most effective interventions, and to inform the policy makers more effectively. 
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